Top Papers

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced... 2014 2026 2018 2022 1.6k
  1. Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial (2014)

Citation Paths

Find how Mei Hou's papers are connected to another author through citations.

Rankless by CCL
2026